Rohtak News Magazine

Positron Emission Tomography Market is Anticipated to Progress at a CAGR of 6.92%, Assesses DelveInsight

 Breaking News
  • No posts were found

Positron Emission Tomography Market is Anticipated to Progress at a CAGR of 6.92%, Assesses DelveInsight

August 31
11:00 2022
Positron Emission Tomography Market is Anticipated to Progress at a CAGR of 6.92%, Assesses DelveInsight

DelveInsight’s Positron Emission Tomography Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Positron Emission Tomography companies in the market.

 

The Positron Emission Tomography market size is expected to surge due to the factors such as the increase in demand for PET Scanners and the growing geriatric population across the globe. In addition, approval and launch of various advanced PET products are anticipated to bolster the market, thereby contributing to the growth of the Positron Emission Tomography market during the forecast period from 2022-2027.

 

Key Takeaways from the Positron Emission Tomography Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global Positron Emission Tomography market during the forecast period.
  • The leading Positron Emission Tomography companies with various Positron Emission Tomography machine such as General Electric Company, Mediso Ltd., Bruker Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, Positron Corporation, Shimadzu Corp., RefleXion, CMR Naviscan Corporation, Segami Corporation, Neusoft Medical Systems Co., Ltd., Sofie Biosciences (PerkinElmer Inc.), United Imaging Healthcare Co., Ltd., MinFound Medical Systems Co., Ltd, MR Solutions, and others are currently dominating the Positron Emission Tomography market.
  • In September 2021, Lantheus Holdings, Inc. and RefleXion Medical Inc. collaborated to evaluate the use of Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent, piflufolastat F 18, to enable real-time therapeutic guidance of biology-guided radiotherapy (BgRT) in prostate cancer with RefleXion’s X1 platform.
  • On March 1, 2021, Shimadzu Corporation released the world’s first TOF-PET System, BresTome TOF-PET functional imaging systems,s dedicated to scanning Brain Tumors, Epilepsy, and Breast Cancers within the Japanese domestic market.
  • On February 12, 2020, Shimadzu Corporation started selling Elmammo dedicated breast PET systems in China. Elmammo systems enable highly accurate breast cancer examinations.

 

Discover more information related to the report- https://www.delveinsight.com/sample-request/positron-emission-tomography-market

 

Positron Emission Tomography Overview

A PET scan positron emission tomography is a type of imaging examination that can reveal the metabolic or biochemical activity of the tissues and organs. The positron emission tomography procedure is frequently performed as an outpatient treatment. Positron emission tomography uses a radioactive substance positron emission tomography tracer, a specific positron emission tomography camera, and a computer to show both normal and abnormal metabolic activity. A PET (positron emission tomography) scan may frequently reveal aberrant positron emission tomography tracer metabolism in disorders before other imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI). The Positron Emission Tomography images are frequently combined with CT or MRI to provide PET-CT (Positron Emission Tomography Computed Tomography) or PET-MRI scans.

 

COVID19 Impact on the Positron Emission Tomography Market

The COVID-19 pandemic had a substantial impact on healthcare systems and that includes diagnostic imaging services. A special report of the Radiological Society of North America COVID-19 task force reported a 40–90% decline in examination volumes in radiology practices during the COVID-19 pandemic. This was due to the outbreak of the pandemic which led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. However, an accurate and detailed understanding of the PET-CT scanning activity during the first wave, and the ability of PET-CT services to recover, contributed to ensuring that management plans for people with cancer which should not be delayed in the future and that relapse of the disease in cancer survivors should be detected in a timely fashion and this resumption of regular healthcare services thereby kept the demand for products on track in the Positron Emission Tomography market.

 

Positron Emission Tomography Market Insights

North America is expected to account for the highest proportion of the global Positron Emission Tomography market, out of all the regions. The rising prevalence of Alzheimer’s disease, rapid technical development activities, increasing awareness for early diagnosis, rising incidences of the aging population, and increased product releases are anticipated to drive the North American Positron Emission Tomography devices market.

 

Positron Emission Tomography Market Dynamics

The Positron Emission Tomography market is witnessing increased product demand for a variety of reasons. A PET scanner is used to detect a wide range of diseases, including cancer, heart disease, brain issues, and other anomalies in the body. It is now utilized in conjunction with Computed Tomography (Positron Emission Tomography CT) and Magnetic Resonance Imaging (MRI) scans to aid in diagnosis. Another important factor driving the Positron Emission Tomography market growth is the growing elderly population across the globe.

 

Scope of the Positron Emission Tomography Market Report

  • Coverage: Global
  • Study Period: 2019-2027
  • Market Segmentation By Type – Full-Ring PET Scanners, Partial Ring PET Scanners
  • Market Segmentation By Application – Oncology, Cardiology, Neurology, Others
  • Market Segmentation By End-User – Hospitals, Diagnostic Imaging Centres, Others
  • Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
  • Key Positron Emission Tomography Companies – General Electric Company, Mediso Ltd., Bruker Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, Positron Corporation, Shimadzu Corp., RefleXion, CMR Naviscan Corporation, Segami Corporation, Neusoft Medical Systems Co., Ltd., Sofie Biosciences (PerkinElmer Inc.), United Imaging Healthcare Co., Ltd., MinFound Medical Systems Co., Ltd, MR Solutions among others
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

 

Request Sample Report- https://www.delveinsight.com/sample-request/positron-emission-tomography-market

 

Table of content

1. Positron Emission Tomography Market Report Introduction

2. Positron Emission Tomography Market Executive Summary

3. Regulatory and Patent Analysis

4. Positron Emission Tomography Market Key Factors Analysis

5. Positron Emission Tomography Market Porter’s Five Forces Analysis

6. COVID-19 Impact Analysis on Positron Emission Tomography Market

7. Positron Emission Tomography Market Layout

8. Positron Emission Tomography Market Global Company Share Analysis – Key 3-5 Companies

9. Positron Emission Tomography Market Company and Product Profiles

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight
Contact Person: Yash
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Related Articles